This adds to the growing body of evidence that suggests ecnoglutide could be a valuable new treatment option for people with type 2 diabetes, offering effective blood sugar control and weight loss, the researchers said
In December 24, for example, Novo Nordisk shares fell 19% after the company reported on late-stage trials for obesity drug CagriSema, which helped patients lose an average of 22.7% of their body weight
34 Furthermore, unlike normal pancreatic cells, pancreatic cancer cells generally demonstrate reduced or absent expression of GLP-1 receptors
Hazzaa et al., 2021)
Ding Y, Shi Y, Guan R et al (2024) Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis
Si el ndice de masa corporal (IMC) de una persona equivale a 30 o ms, la persona es considerada obesa